Stockreport

Unicycive resubmits NDA for hyperphosphatemia asset [Seeking Alpha]

Unicycive Therapeutics, Inc.  (UNCY) 
PDF In late June, the company received a Complete Response Letter for the oral phosphate binder due to issues at a third-party manufacturer. CEO Shalabh Gupta said in a n [Read more]